Joe Biden Archives

Politics By Lev Facher

On Covid messaging, Biden is caught between politics and public health

Hospitals By Bob Herman

New Jersey hospitals scrap merger after FTC challenge

Exclusive By Rachel Cohrs

Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb

Politics By Lev Facher

Francis Collins on his new life as White House science adviser

Hospitals By Tara Bannow

The FTC says it’s getting tougher on hospital consolidation. Antitrust experts aren’t buying it

Exclusive By Nicholas Florko

Prisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugs

Health By Megan Molteni

Covid’s circling the White House. What are the risks to someone like Biden?

Exclusive By Rachel Cohrs

White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process

Politics By Lev Facher

A new nonprofit wants to rewrite the playbook for how the U.S. government funds science

Politics By Lev Facher

Biden’s new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on

Politics By Rachel Cohrs

Medicare finalizes its restrictions on new Alzheimer’s drug, despite pressure from drugmakers

Politics By Rachel Cohrs

Biden administration ramps up long Covid research efforts following criticism

Exclusive By Lev Facher

NIH’s cancer chief, Ned Sharpless, to step down

Politics By Rachel Cohrs

Senate nears $10 billion deal to buy Covid vaccines, therapeutics

Exclusive By Lev Facher

Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist

Politics By Rachel Cohrs

CMMI’s Fowler on health policy’s ‘stubborn challenges,’ her personal ties to medicine

Exclusive By Lev Facher

Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence

Politics By Rachel Cohrs

‘A slow-moving glacier’: NIH’s sluggish and often opaque efforts to study long Covid draw patient, expert ire

Special Report By Lev Facher

NIH’s identity crisis: The pandemic and the search for a new leader leave the agency at a crossroads

Politics By Lev Facher and Damian Garde

The new White House Covid coordinator is great on TV. Is that what America’s pandemic response needs now?

Politics By Nicholas Florko

Lawmakers face off about the future of the FDA’s accelerated approval pathway

D.C. Diagnosis By Nicholas Florko

Covid budget crunch looms over government funding fight

Health By Andrew Marquardt — Medill News Service

Doctors, companies push to keep looser, pandemic-era rules for prescribing opioid addiction treatment via telemedicine

Politics By Rachel Cohrs

White House transparency disputes imperil funds to buy Covid therapeutics

Special Report By Rachel Cohrs

Most Read

‘Too little too late’: Unpacking Biden’s moves to improve federal prisons’ response to Covid-19

Francis Collins: Concern about independence of new moonshot science agency ARPA-H are ‘overblown’

How the Covid-19 pandemic prepared the White House to respond to monkeypox

Biden administration won’t lower seniors’ Medicare premiums this year, despite changes to coverage of new Alzheimer’s drug

As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms

What happens when the government stops buying Covid-19 vaccines?

The panel was supposed to improve efficiency at the NIH. It hasn’t even met for 7 years

White House documents detail a looming squeeze on Covid-19 boosters

All Coverage

On Covid messaging, Biden is caught between politics and public health

New Jersey hospitals scrap merger after FTC challenge

Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb

Francis Collins on his new life as White House science adviser

The FTC says it’s getting tougher on hospital consolidation. Antitrust experts aren’t buying it

Prisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugs

Covid’s circling the White House. What are the risks to someone like Biden?

White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process

A new nonprofit wants to rewrite the playbook for how the U.S. government funds science

Biden’s new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on

Medicare finalizes its restrictions on new Alzheimer’s drug, despite pressure from drugmakers

Biden administration ramps up long Covid research efforts following criticism

NIH’s cancer chief, Ned Sharpless, to step down

Senate nears $10 billion deal to buy Covid vaccines, therapeutics

Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist

CMMI’s Fowler on health policy’s ‘stubborn challenges,’ her personal ties to medicine

Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence

‘A slow-moving glacier’: NIH’s sluggish and often opaque efforts to study long Covid draw patient, expert ire

NIH’s identity crisis: The pandemic and the search for a new leader leave the agency at a crossroads

The new White House Covid coordinator is great on TV. Is that what America’s pandemic response needs now?

Lawmakers face off about the future of the FDA’s accelerated approval pathway

Covid budget crunch looms over government funding fight

Doctors, companies push to keep looser, pandemic-era rules for prescribing opioid addiction treatment via telemedicine

White House transparency disputes imperil funds to buy Covid therapeutics

Why formally ending the pandemic is going to be a huge headache for the entire health care system

Subscribe to STAT for $15 per month lorem ipsum